GSK plc.
Company Snapshot
Founded: 1999
Entity Type: Public
Employees: 68,629
Region: U.S.
Revenue: $40,096.2 Millions
Revenue Year: 2024
Segment: Speciality Medicines
Headquarter: Brentford, U.K.
Key Geographics: U.S., Europe, U.K.
Company Overview
In January 2000, Glaxo Wellcome plc merged with SmithKline Beecham plc to form GlaxoSmithKline (GSK) plc., a global biopharma company. In July 2022, GSK Group separated its Consumer Healthcare business from the GSK Group to form Haleon plc, an independent consumer health company. The Consumer Healthcare business was a joint venture between GSK and Pfizer Inc., with GSK holding a majority controlling interest of 68% and Pfizer holding 32%. Following the demerger, GSK focuses solely on biopharmaceuticals, prioritizing investment toward the development of innovative vaccines and specialty medicines.
The company operates in more than 80 countries and sells its products in 122 countries.
GSK plc. In News
Company's Business Segments
- Speciality Medicines : HIV, Oncology, Immuno-inflammation, respiratory and other
- Vaccines : Meningitis, Influenza, Shingles, Established Vaccines
- Other General Medicines : Respiratory, Other General Medicines
- General Medicines
Applications/End User Industries
- Healthcare Providers
- Hospitals
- Pharmacies
- Wholesalers
- Governments
- Research Institutions
BCC Research Beacon 